Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 268 followers
Latest posts
Last updated 5 minutes ago
Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised
6 minutes ago
Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation...
Human medicines European public assessment report (EPAR): Voydeya, danicopan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
29 minutes ago
Human medicines European public assessment report (EPAR): Voydeya, danicopan, Date of authorisation...
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 14, Status: Authorised
39 minutes ago
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation...
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 16, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation...
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation...
Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Date of authorisation: 17/02/2015, Revision: 13, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous...
Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 17, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation...
Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation...
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 23, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Date of authorisation: 15/05/2023, Revision: 3, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Date of authorisation...
Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revi
4 days ago
Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell...
Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and varicella vaccine (live), Date of authorisation: 05/04/2006, Revision: 34, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and...